Brca1 breast tumors contain distinct CD44+/CD24- and CD133+cells with cancer stem cell characteristics
Open Access
- 1 February 2008
- journal article
- Published by Springer Science and Business Media LLC in Breast Cancer Research
- Vol. 10 (1), R10
- https://doi.org/10.1186/bcr1855
Abstract
Whether cancer stem cells occur in BRCA1-associated breast cancer and contribute to therapeutic response is not known.Keywords
This publication has 45 references indexed in Scilit:
- Molecular analysis reveals heterogeneity of mouse mammary tumors conditionally mutant for Brca1Molecular Cancer, 2008
- Harnessing genetically engineered mouse models for preclinical testingChemico-Biological Interactions, 2008
- Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumorsGenome Biology, 2007
- Tumour-initiating cells vs. cancer ‘stem’ cells and CD133: What’s in the name?Biochemical and Biophysical Research Communications, 2007
- Inhibition of Hsp90 Compromises the DNA Damage Response to RadiationCancer Research, 2006
- Identification of murine mammary stem cells: implications for studies of mammary development and carcinogenesisBreast Cancer Research, 2006
- RNA interference-triggered reversal of ABCC2-dependent cisplatin resistance in human cancer cellsBiochemical and Biophysical Research Communications, 2006
- Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2Science, 2003
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences, 2003
- CD44 in CancerCritical Reviews in Clinical Laboratory Sciences, 2002